Scholars@Duke publication: Disparities in utilization of oral anticancer agents and related costs in elderly patients with metastatic renal cell carcinoma in the United States.

Disparities in utilization of oral anticancer agents and related costs in elderly patients with metastatic renal cell carcinoma in the United States.

Publication , Conference

Wilson, LE; Spees, L; Pritchard, J; Greiner, MA; Scales, CD; Baggett, C; Kaye, D; George, DJ; Zhang, T; Wheeler, SB; Dinan, MA

Published in: JOURNAL OF CLINICAL ONCOLOGY

2020

JOURNAL OF CLINICAL ONCOLOGY

1527-7755

0732-183X

2020

APA

Chicago

ICMJE

MLA

NLM

Wilson, L. E., Spees, L., Pritchard, J., Greiner, M. A., Scales, C. D., Baggett, C., … Dinan, M. A. (2020). Disparities in utilization of oral anticancer agents and related costs in elderly patients with metastatic renal cell carcinoma in the United States. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 38).

Wilson, Lauren E., Lisa Spees, Jessica Pritchard, Melissa A. Greiner, Charles D. Scales, Chris Baggett, Deborah Kaye, et al. “Disparities in utilization of oral anticancer agents and related costs in elderly patients with metastatic renal cell carcinoma in the United States.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 38, 2020.

Wilson LE, Spees L, Pritchard J, Greiner MA, Scales CD, Baggett C, Kaye D, George DJ, Zhang T, Wheeler SB, Dinan MA. Disparities in utilization of oral anticancer agents and related costs in elderly patients with metastatic renal cell carcinoma in the United States. JOURNAL OF CLINICAL ONCOLOGY. 2020.

JOURNAL OF CLINICAL ONCOLOGY

1527-7755

0732-183X

2020